<DOC>
	<DOCNO>NCT00724594</DOCNO>
	<brief_summary>The purpose trial find best dose N-acetylcysteine ( NAC ) decrease brain injury baby expose intrauterine infection without cause significant side effect .</brief_summary>
	<brief_title>Safety N-acetylcysteine Maternal Chorioamnionitis ( NAC Chorio )</brief_title>
	<detailed_description>Chorioamnionitits infection fluid membrane surround baby utero . Intrauterine infection associate significant white grey matter brain injury newborn particularly important pathogenesis periventricular leukomalacia ( PVL ) cerebral palsy ( CP ) . CP show 4-9 time high baby expose intrauterine infection normal infant . Antibiotics change risk brain injury newborn . NAC promise anti-oxidant therapy show effective neuroprotection animal model chorioamnionitis , favorable safety profile limit manageable side effect . In trial , intravenous NAC give mother antenatally infant postnatally , present diagnosis chorioamnionitis , evaluate safety pharmacokinetics ( PK ) mother infant . Mothers ≥24 week gestation infant randomize receive either saline NAC within 4 hour clinical diagnosis chorioamnionitis . Infants stratified term ( ≥ 33wk ) preterm ( 24-32wk ) cohort , due different expect rate metabolism clearance . Information gain trial use determine rapidly NAC metabolize mother , fetus , infant , ability NAC cross placenta . This study also elucidate safety NAC set chorioamnionitis fetal neuroprotection .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Chorioamnionitis</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Participants follow qualify : Chorioamnionitis , define either 1 ) clinical diagnosis choriomanionitis 2 ) maternal fever great equal 100 degree F presence rupture membranes 2 following : uterine tenderness , maternal WBC &gt; 15,000 cells/mm , fetal tachycardia &gt; 160 bpm , malodorous amniotic fluid , preterm group , rupture membrane active preterm labor . Gestational age ≥ 24 complete week , first trimester ultrasound date last menstrual period . No great 4 hour onset fever diagnosis . Participants none following : Asthma , steroiddependent Clinical sepsis , whether viral bacterial nature , define fever sign cardiovascular compromise mother ( blood pressure &lt; 90/50 , heart rate &gt; 120 bpm , need oxygen due maternal saturation 92 % , pneumonia , pyelonephritis , meningitis ) Seizure disorder Fetal weight biparietal diameter le 10th % gestational age Suspected major genetic congenital abnormality Fetal distress demand immediate delivery ( poor fetal biophysical profile , late deceleration , sinusoidal fetal heart rate pattern ) Participation another therapeutic clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>chorioamnionitis</keyword>
	<keyword>maternal chorioamnionitis</keyword>
	<keyword>neonatal white matter injury</keyword>
	<keyword>N-acetylcysteine</keyword>
	<keyword>NAC</keyword>
	<keyword>anti-oxidant treatment</keyword>
</DOC>